Evidence map›Paper›PMID 27774472›Full record

ReviewHypoxia (Auckland, N.Z.)2014

Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism.

Ming Yang, Huizhong Su, Tomoyoshi Soga, Kamil R Kranc, Patrick J Pollard

Open access · diamondAbstract readReview
In one paragraph

Review in Hypoxia (Auckland, N.Z.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. THY1Nature cell biology · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects.Cellular and molecular life sciences : CMLS · 2025
    Review
  13. Quassinoids as Promising Anti-cancer Agents.Current medicinal chemistry · 2025
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Ming YangCancer Biology and Metabolism Group, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Huizhong SuCancer Biology and Metabolism Group, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Tomoyoshi SogaInstitute for Advanced Biosciences, Keio University, Mizukami, Tsuruoka, Yamagata, Japan.
Kamil R KrancMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
Patrick J PollardCancer Biology and Metabolism Group, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
University of Edinburgh · GBKeio University · JPMRC Centre for Regenerative Medicine · GB

Funding

European Research Council 310837
6 · The paper itself

Abstract

The hypoxia-inducible factor (HIF) prolyl hydroxylase domain enzymes (PHDs) regulate the stability of HIF protein by post-translational hydroxylation of two conserved prolyl residues in its α subunit in an oxygen-dependent manner.

Indexed as

2-oxoglutarate-dependent dioxygenaseshydroxylationhypoxia-inducible factor (HIF)metabolismmouse modelsprolyl hydroxylase domain (PHD)

Identifiers

PMID27774472
PMCPMC5045062
OpenAlexW2036354935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.